Literature DB >> 1137560

Reduction of the size of acute, experimental myocardial infarction by Verapamil.

W Wende, W Bleifeld, J Meyer, H W Stühlen.   

Abstract

The effect of 0.1 mg/kg Verapamil on the extent of the ischemic area following ligation of a branch of the left descending coronary artery was studied in anesthetized open chest dogs. The sum of the ST-segment elevation during the entire period of occlusion in the epicardial ECG was 15 mV in control infarction compared to 9 mV (p smaller than 0.0005) when Verapamil was infused after ligation. Mean flow in the left descending coronary artery was reduced by coronary ligation alone on the average by 23%, but augmented by Verapamil for 5% above pre-occlusion control flow. Corresponding to the rise in the coronary flow and the drop in perfusion pressure under the influence of Verapamil, the increase of left coronary artery resistance induced by coronary occlusion was diminished. The positive effect of Verapamil on the size of myocardial infarction as estimated from the epicardial ST-segment changes is probably not induced by coronary vasodilatation, but by the Ca-antagonizing effect of this drug, as described by other authors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137560     DOI: 10.1007/bf01905620

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  23 in total

1.  [(N-methyl-N-homoveratryl)-gamma-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile, a substance with coronary vasodilating properties].

Authors:  H HAAS; G HAERTFELDER
Journal:  Arzneimittelforschung       Date:  1962-06

2.  [Effect of Verapamil on the metabolism of myocardium].

Authors:  H Haas; M Gokel
Journal:  Arzneimittelforschung       Date:  1970-05

3.  [Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers].

Authors:  A Fleckenstein; H J Döring; H Kammermeier
Journal:  Klin Wochenschr       Date:  1968-04-01

4.  Activation of vascular smooth muscle of rat aorta by noradrenaline and depolarization: two different mechanisms.

Authors:  U Peiper; L Griebel; W Wende
Journal:  Pflugers Arch       Date:  1971       Impact factor: 3.657

5.  [The effect of iproveratril on angina pectoris and thef adrenergic beta-receptors of man].

Authors:  M Kaltenbach; D Zimmermann
Journal:  Dtsch Med Wochenschr       Date:  1968-01-05       Impact factor: 0.628

6.  On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs.

Authors:  K I Melville; H L Garvey; H E Shister
Journal:  Rev Can Biol       Date:  1968-09

7.  [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].

Authors:  A Fleckenstein
Journal:  Arzneimittelforschung       Date:  1970-09

8.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

9.  [Inotropic effects of extracellular Ca plus 2-variation on isolated heart muscle cells cultured in vitro].

Authors:  H Tritthart; R Kaufmann; B Rost
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

10.  [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].

Authors:  G Grün; A Fleckenstein
Journal:  Arzneimittelforschung       Date:  1972-02
View more
  5 in total

1.  [Influence of a streptokinase-induced fibrinolysis on the extent of the acute experimental myocardial infarction (author's transl)].

Authors:  W Wende; H W Stühlen; J Meyer; W Bleifeld; H Holzhüter; E Wenzel
Journal:  Klin Wochenschr       Date:  1975-08-15

2.  The haemodynamic and metabolic effects of MG 8926, a prospective antidysrhythmic and antianginal agent.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

3.  The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  Evaluation of the protective effect of verapamil on reperfusion injury by 111In anticardiac myosin antibody in canine myocardial infarction.

Authors:  J K Chung; S M Lim; M C Lee; C S Koh; M Lee; J W Seo
Journal:  Ann Nucl Med       Date:  1991-09       Impact factor: 2.668

5.  Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.

Authors:  L W DeBoer; H W Strauss; R A Kloner; R E Rude; R F Davis; P R Maroko; E Braunwald
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.